Get startedLog in
    Picture of GlaxoSmithKline Pharmaceuticals logo

    GLAXO — GlaxoSmithKline Pharmaceuticals News Story

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: Glaxosmithkline Pharmaceuticals Estimates Impact Of NLEM Price Revisions

    Picture of GlaxoSmithKline Pharmaceuticals logoGlaxoSmithKline Pharmaceuticals
    16/03/2023 10:55
    March 16 (Reuters) - GlaxoSmithKline Pharmaceuticals Ltd  GLAX.NS :
    * GLAXOSMITHKLINE PHARMACEUTICALS - ESTIMATED IMPACT OF NLEM PRICE REVISIONS; WORKING ON
MULTIPLE
MITIGATIONS
    * GLAXOSMITHKLINE PHARMACEUTICALS -  EXPECT  IMPACT ON PROFITS TO BE IN LOW SINGLE DIGITS IN
NEXT
FINANCIAL YEAR

Source text for Eikon:  ID:nBSE2XrQPN 
Further company coverage:  GLAX.NS 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on GlaxoSmithKline Pharmaceuticals

    See all news